Introduction: Marginal Investment Scheme for Reducing Import Dependence

India’s medical device industry has witnessed remarkable growth in recent years. However, a significant share of advanced medical devices, components, accessories, and raw materials is still imported. This dependence on imports increases manufacturing costs, exposes businesses to global supply chain disruptions, and affects the country’s self-reliance in healthcare manufacturing.

To address this challenge, the Government of India introduced the Marginal Investment Scheme for Reducing Import Dependence under the Strengthening of Medical Device Industry Scheme. This initiative encourages manufacturers to invest in domestic production of key medical devices, components, accessories, and upstream materials through financial assistance linked to fresh investment.

For businesses planning to establish or expand manufacturing facilities, this initiative creates an excellent opportunity to reduce project costs through government support. However, successful implementation requires proper project planning, eligibility assessment, documentation, and financial structuring. This is where Finraja Consultancy Private Limited assists manufacturers by providing end-to-end subsidy consulting services, from project evaluation to grant claim support.

What is the Marginal Investment Scheme for Reducing Import Dependence?

The Marginal Investment Scheme for Reducing Import Dependence is a dedicated financial assistance program designed to encourage domestic manufacturing of medical devices and critical components that are currently imported into India. Instead of providing routine operational subsidies, the scheme supports fresh capital investment in eligible manufacturing projects.

Its primary objective is to strengthen India’s manufacturing capability for medical devices while encouraging investment in key components, raw materials, accessories, and closely related products used in the production of medical devices. The scheme also supports manufacturing of selected medical devices that currently rely heavily on imports, helping improve domestic availability and long-term competitiveness.

Unlike general industrial incentives, this Medical Device Manufacturing Subsidy India initiative specifically targets investment that reduces import dependence and contributes to India’s healthcare manufacturing ecosystem.

Eligibility Criteria

The operational guideline specifies that an applicant should satisfy the prescribed conditions before becoming eligible for financial assistance.

Key eligibility requirements include:

• Fresh investment should be made in eligible products.
• Manufacturing must relate to eligible medical devices, components, accessories, or upstream materials.
• Investment should comply with the notified scheme guidelines.
• Project proposals should contain all required technical and financial information.
• Applicants should submit supporting documentation as prescribed.
• Investment should contribute toward reducing import dependence.

Since project approval depends upon multiple technical and financial parameters, proper documentation becomes extremely important during application preparation.

Eligible Activities under the Scheme

The Medical Device Component Manufacturing Subsidy supports manufacturing activities involving products identified under the notified list.

Indicative eligible activities include investment for manufacturing:

• Medical devices
• Medical device components
• Medical device accessories
• Upstream materials
• Raw materials
• Closely related products used in medical device manufacturing

These activities are selected because they strengthen domestic value chains and reduce dependence on imported products used by the medical device industry.

Financial Incentives under the Marginal Investment Scheme for Reducing Import Dependence

One of the biggest advantages of this Medical Device Investment Subsidy is the financial assistance provided against eligible fresh investment.

The scheme provides financial assistance equal to 25% of eligible investment, subject to the applicable maximum ceiling based on the investment slab.

Central/State Government Organizations will be supported with a grant of 20% of the investment in the eligible project or 10 crore, whichever is less.

Physical and Financial Outlay

Financial Assistance

Receiving approval does not automatically result in the release of the entire grant amount. The operational guideline provides for phased disbursement based on project progress and utilization of previous installments.

The grant is released in four equal installments:

The applicant is also required to submit utilization certificates, expenditure details, and other prescribed documents before subsequent installments are released.

How Finraja Consultancy Private Limited Can Help

At Finraja Consultancy Private Limited, we specialize in government subsidy consulting for manufacturing and industrial projects. Our team assists businesses throughout the subsidy lifecycle, enabling them to focus on project execution while we manage the documentation and compliance process.

Services:

• Initial eligibility assessment.
• Scheme selection and advisory.
• Preparation of Detailed Project Reports (DPRs).
• Financial feasibility analysis.
• Capital investment planning.
• Documentation support.
• Application preparation.
• Liaison and coordination support.
• Assistance during appraisal.
• Post-approval compliance.
• Grant claim documentation.
• Ongoing subsidy management support.

The objective is to simplify the subsidy process and help businesses maximize the benefits available under eligible government schemes.

FAQs

1. What is the Marginal Investment Scheme for Reducing Import Dependence?

It is a government initiative under the Department of Pharmaceuticals that provides financial assistance for eligible investments in domestic manufacturing of notified medical devices, components, accessories, and upstream materials to reduce dependence on imports.

2. Who can apply under this scheme?

Eligible manufacturers proposing fresh investment in notified products and meeting the prescribed eligibility conditions may apply, subject to the operational guidelines.

3. What financial assistance is available?

The scheme provides financial assistance at 25% of eligible investment, subject to the applicable investment slabs, maximum ceilings, and approval conditions specified in the guidelines.

4. Is a Detailed Project Report mandatory?

Yes. A comprehensive DPR with technical, financial, operational, and implementation details forms a key part of the project proposal and appraisal process.

5. Can Finraja Consultancy Private Limited assist with the application?

Yes. Finraja provides end-to-end assistance, including eligibility assessment, DPR preparation, financial analysis, documentation, application support, compliance, and post-approval advisory.

Conclusion

The Marginal Investment Scheme for Reducing Import Dependence presents a significant opportunity for manufacturers seeking to strengthen India’s medical device ecosystem while reducing reliance on imported products. By supporting investments in eligible medical devices, components, accessories, and upstream materials, the scheme encourages domestic manufacturing, technological advancement, and long-term industrial growth.

If your organization is planning a medical device manufacturing project and wants to evaluate eligibility under this scheme, Finraja Consultancy Private Limited can help you navigate every stage—from project conceptualization and DPR preparation to application submission and grant support—so you can pursue government incentives with confidence.

Call us now: +91 9373114747 or visit finraja.com/contact for quick assistance.